United Kingdom Point-of-care Glucose Testing Market Insight
United Kingdom Point-of-care Glucose Testing Market is growing at an 3.5% CAGR, driven by rising diabetes prevalence, home-monitoring demand, NHS initiatives, rapid diagnostics, and portable glucose testing innovations.
United Kingdom Point-of-care Glucose Testing Market Insights Forecasts to 2035
- The United Kingdom Point-of-care Glucose Testing Market Size Was Estimated at USD 229.5 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 3.5% from 2025 to 2035
- The United Kingdom Point-of-care Glucose Testing Market Size is Expected to Reach USD 323.6 Million by 2035
Notable Insights for United Kingdom Point-of-care Glucose Testing Market
- By product type, glucose meters and testing strips dominated, accounting for approximately 75% share in 2024, supported by routine diabetes monitoring demand.
- By end user, hospitals and home care settings dominated, holding approximately 70% share due to increasing diabetic patient monitoring and self-testing adoption.
- Approximately 8% of the UK population is living with diabetes, increasing demand for rapid and accessible glucose monitoring technologies nationwide.
Download the eBook (ToC)
- Around 85% of diabetic patients utilize point-of-care or self-monitoring glucose devices regularly, while continuous glucose monitoring adoption continues expanding steadily.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Point-of-care Glucose Testing Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Point-of-care Glucose Testing Market
- Abbott Laboratories
- Roche Diagnostics
- Dexcom
- Medtronic
- Ascensia Diabetes Care
- Nova Biomedical
- Siemens Healthineers
- LifeScan
- EKF Diagnostics
- Others
Recent Developments:
- In April 2026: Roche Diagnostics highlighted the Accu-Chek SmartGuide AI-enabled CGM system at the Diabetes UK Professional Conference, introducing predictive nighttime hypoglycaemia alerts and advancing smart point-of-care glucose monitoring technologies in the UK.
- In February 2025: Spirit Health launched the CareSens Air CGM on the UK Drug Tariff, offering affordable 15-day real-time glucose monitoring and expanding patient access to cost-effective continuous glucose testing solutions.
Market Segmentation:
United Kingdom Point-of-care Glucose Testing Market, By Product Type
- Glucose Meters
- Testing Strips
- Lancets
- Continuous Glucose Monitoring Devices
- Others
United Kingdom Point-of-care Glucose Testing Market, By Mode of Testing
- Hospital-Based Testing
- Home Care Testing
- Diagnostic Laboratory Testing
United Kingdom Point-of-care Glucose Testing Market, By End User
- Hospitals & Clinics
- Home Care Settings
- Diagnostic Centres
- Ambulatory Care Centres
United Kingdom Point-of-care Glucose Testing Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Channels
Expert Views:
The UK Point-of-Care Glucose Testing Market is projected to have a positive outlook due to the rise in diabetes cases, an increase in consumer demand for home testing, and NHS campaigns for earlier detection and digital health care incorporation. It is important to note that continuous glucose monitoring systems and mobile point-of-care testing products will remain key factors behind progress in the industry. Innovations, wireless capabilities, and enhanced funding programs are forecasted to enhance market growth until 2035.